“The ‘A-‘ rating reflects our view of BMHC’s reduced operating losses, solid and competitive market share in a fairly large service area, strategic initiatives that could help increase revenue and further improve operations and acceptable pro forma unrestricted reserves,” said S&P analyst Suzie Desai.
The outlook is negative, reflecting S&P’s view of BMHC’s continued operating losses through interim 2016 that aren’t indicative of a credit in the “A” category.
More articles on healthcare finance:
5 study findings on health spending related to opioid addiction treatment
Cayman hospital system OKs large debt write-off
UnitedHealth’s Optum takes over Quest Diagnostics’ billing processes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
